Chemed Co. (NYSE:CHE) Holdings Lifted by Blair William & Co. IL

Blair William & Co. IL raised its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 3.2% during the 2nd quarter, Holdings Channel reports. The fund owned 2,476 shares of the company’s stock after purchasing an additional 76 shares during the period. Blair William & Co. IL’s holdings in Chemed were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of CHE. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Chemed in the first quarter worth about $1,064,000. ProShare Advisors LLC increased its stake in shares of Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock valued at $32,482,000 after acquiring an additional 49,808 shares during the period. Cim LLC bought a new stake in Chemed during the fourth quarter worth approximately $1,328,000. Sei Investments Co. lifted its position in Chemed by 4.5% in the first quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after purchasing an additional 1,780 shares during the period. Finally, American National Bank & Trust Co. VA bought a new position in Chemed during the 1st quarter valued at $3,122,000. Institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In related news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at approximately $3,478,159.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the transaction, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,744 shares of company stock valued at $3,828,231. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Performance

CHE opened at $589.28 on Tuesday. The company has a market capitalization of $8.92 billion, a PE ratio of 31.72, a P/E/G ratio of 2.31 and a beta of 0.44. The stock’s fifty day moving average is $570.39 and its 200-day moving average is $576.80. Chemed Co. has a one year low of $497.36 and a one year high of $654.62.

Chemed (NYSE:CHEGet Free Report) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same quarter last year, the firm posted $4.71 earnings per share. Chemed’s revenue was up 7.6% compared to the same quarter last year. On average, equities research analysts forecast that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were given a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed’s payout ratio is 10.76%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.